HBsAG combined with the immunostimulatory sequence 1018 ISS can provide effective and lasting seroprotection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1608, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunostimulatory DNA - Dynavax: AIC, Amb a 1 Immunostimulatory Conjugate, HBV-ISS, ISS 1018, ISS DNA, ISS DNA - Dynavax, ISS1, ISS2

Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. : 193-196

Adis International

Access to resources Recommend Favorite

Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

1018 ISS vaccine provides sharp immune response for hepatitis B

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Hepatitis-B Surface Antigen (HBsAg) Powder Formulation: Process and Stability Assessment

Current Drug Delivery, Vol. 4, Iss. 1, 2007-01 ,pp. : 57-67

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 17, Iss. 1, 2017-03 ,pp. : 24-35

Bentham Science Publishers

Access to resources Recommend Favorite